UK markets open in 5 hours 44 minutes
NIKKEI 225
38,179.32 -94.73 (-0.25%) HANG SENG
17,763.03 0.00 (0.00%) CRUDE OIL
79.20 +0.20 (+0.25%) GOLD FUTURES
2,335.90 +24.90 (+1.08%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,076.74 -1,717.45 (-3.59%)
Galectin Therapeutics, Inc. (GALT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 3.5100 |
| Open | 3.5500 |
| Bid | 3.4500 x 100 |
| Ask | 3.5300 x 100 |
| Day's range | 3.4600 - 3.6200 |
| 52-week range | 1.2800 - 4.2700 |
| Volume | |
| Avg. volume | 160,665 |
| Market cap | 216.663M |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Galectin Therapeutics Inc (GALT) Reports 2023 Financial Results and Business Developments
Comparing GALT's Performance Against Analyst Estimates and Exploring Future Prospects
- Simply Wall St.
Retail investors account for 55% of Galectin Therapeutics Inc.'s (NASDAQ:GALT) ownership, while insiders account for 21%
Key Insights Galectin Therapeutics' significant retail investors ownership suggests that the key decisions are...
- Simply Wall St.
Galectin Therapeutics Inc. (NASDAQ:GALT) surges 16%; individual investors who own 59% shares profited along with insiders
Key Insights Significant control over Galectin Therapeutics by individual investors implies that the general public has...
© 2024 Yahoo. All rights reserved.